Download Networks of Innovation: Vaccine Development at Merck, Sharp by Louis Galambos PDF
By Louis Galambos
Networks of Innovation deals a ancient standpoint at the demeanour during which deepest quarter companies have obtained, sustained, and periodically misplaced the power to boost, manufacture, and marketplace new serum antitoxins and vaccines. the first concentration is at the H. ok. Mulford corporation, on Sharp & Dohme, which obtained Mulford in 1929, and on Merck & Co., Inc., which merged with Sharp & Dohme in 1953. by means of surveying a century of innovation in biologicals, the authors exhibit how the actions of those 3 advertisement firms have been concerning a sequence of advanced, evolving networks of medical, governmental, and scientific associations within the usa and overseas.
Read or Download Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995 PDF
Similar special topics books
From the time of Hippocrates until eventually the Nineteen Twenties, massaging girl sufferers to orgasm was once a staple of scientific perform between Western physicians within the therapy of "hysteria," an disease as soon as thought of either universal and protracted in girls. medical professionals loathed this time-consuming technique and for hundreds of years depended on midwives.
Fix of straightforward and intricate belly hernias by way of the laparoscopic strategy is now the strategy of selection in lots of facilities. Laparoscopic fix bargains identical results to open fix, with the extra merits of better sufferer pride and lowered hospitalization. For a few hernias, significantly incisional and hiatal, the end result seems to be greater utilizing the minimally invasive method.
This e-book examines 4 scientific suggestions that epitomize the pitfalls of development: DES, a man-made estrogen prescribed to thousands of girls to avoid miscarriages, which produced devastating unwanted side effects; the factitious middle; the 1976 swine flu immunization software; and genetic engineering. Dutton and the members hint the human offerings that govern clinical and clinical innovation and discover the political, monetary, and social elements that impression these offerings.
Drawing upon a myriad of fundamental and secondary ancient assets, The Royal medical professionals: scientific team of workers on the Tudor and Stuart Courts investigates the influential people who attended England's most vital sufferers in the course of a pivotal epoch within the evolution of the country and the clinical career.
Additional resources for Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995
229-379. S. Public Health Service, pp. 118-75, 4 1 1 - 3 5 , 5 6 0 611. Harden, Inventing the NIH, especially pp. 71-159. Elizabeth Fee, Disease and Discovery: A History of the Johns Hopkins School of Hygiene and Public Health, 1916-1939 (Baltimore, 1987), especially pp. 57-154. Duffy, Public Health in New York City, pp. 307-31- A. Yankauer, "The American Journal of Public Health, 1911-85," American Journal of Public Health 76, no. 7 (1986): 8 0 9 - 1 5 . 58 Duffy, Public Health in New York City, pp.
2 (1934): 9; "The Preferred Diphtheria Prophylactic," in 3, no. 1 (1930): 2 - 3 ; and "Diphtheria Products," in 3, no. 12 (1931): 3 - 7 . S&D Abstract 9, no. 2 (1936): 16-18. All in MA. 13 See Scientific Information on Sharp & Dohme Products, Letter No. 1, June 1, 1937, through Letter No. 51, Dec. 30, 1938. Sharp & Dohme, Pharmaceuticals, Mulford Biologicals, Oct. 1, 1945. Sharp & Dohme, Catalogue No. 5 1, Pharmaceuticals, Biologicals, May 15, 1952. See also the "Medical Corner," in S & D Extract 5, no.
A. D. Melvin to the Surgeon General, Oct. 8 and 19, 1915; A. Eichhorn to Surgeon General Rupert Blue, Oct. 19, 1915, with enclosure; A. Eichhorn, "Vaccination Experiments Against Anthrax," c. S. National Archives (hereafter RG 90, NA). 29 H. K. Mulford Company, Price-List, Aug. 1898, MA. Dr. W. F. Elgin, "A Quarter Century of Vaccine Production with H. K. ," manuscript, MA. As Elgin pointed out, the firm also introduced process innovations, learning for instance how to keep the glycerinated virus in cold storage.